•
Dec 31, 2022

Akoya Q4 2022 Earnings Report

Akoya reported record revenue driven by robust demand for its spatial biology solutions.

Key Takeaways

Akoya Biosciences reported a 31% increase in revenue for Q4 2022, reaching $21.2 million compared to $16.2 million in the prior year period. The company's product revenue increased by 22% to $15.7 million, while services and other revenue grew by 70% to $5.5 million. Gross profit was $12.0 million with a gross profit margin of 57%.

Total revenue reached $21.2 million, a 31% increase year-over-year.

Product revenue increased by 22% to $15.7 million.

Services and other revenue grew by 70% to $5.5 million.

Gross profit was $12.0 million with a gross profit margin of 57%.

Total Revenue
$21.2M
Previous year: $16.2M
+31.3%
EPS
-$0.5
Previous year: -$0.47
+6.4%
Gross Profit
$12M
Previous year: $10.2M
+17.8%
Cash and Equivalents
$74.2M
Previous year: $113M
-34.4%
Free Cash Flow
-$10.9M
Previous year: -$7.22M
+50.7%
Total Assets
$176M
Previous year: $191M
-7.8%

Akoya

Akoya

Akoya Revenue by Segment

Forward Guidance

The Company expects a full year 2023 revenue guidance range of $95-98 million.

Revenue & Expenses

Visualization of income flow from segment revenue to net income